ClinConnect ClinConnect Logo
Search / Trial NCT06649175

Effect of Kinetic Chain Exercises on Muscle Strength, Joint Position Sense and Quality of Life in Children with Haemophilia.

Launched by CAIRO UNIVERSITY · Oct 17, 2024

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is studying whether a specific type of exercise, called close kinetic chain exercises, can help improve muscle strength, joint position sense, and the overall quality of life for children with hemophilia. The researchers want to see if these exercises can make a positive difference in how children with this condition feel and function, compared to not doing these exercises at all.

To participate in the trial, children must be between 5 and 7 years old, receive regular preventive treatment for their hemophilia, and be able to stand and walk on their own. They should also be able to follow instructions during the evaluations and treatments. However, children will not be eligible if they have certain issues, like problems with their vision or hearing, serious joint or bone problems, recent surgeries, or bleeding in their joints before the assessments. The trial is not yet recruiting participants, but when it starts, children who qualify can expect to take part in a program that focuses on exercise and monitor how it affects their strength and well-being.

Gender

MALE

Eligibility criteria

  • Inclusion Criteria:
  • 1. Their chronological age will be 5-7yeasr. 2. All children will receive prophylaxis therapy. 3. They will able to stand and walk independently. 4. They will be able to follow instructions during evaluation and treatment.
  • Exclusion Criteria:
  • * The children will be excluded if they have one of the following:
  • 1. Visual or auditory problem.
  • 2. Radiographic changes as bone erosions, destruction, or joint subluxation, or congenital or acquired skeletal deformities in both lower limbs.
  • 3. Surgical procedures performed six weeks prior to or during study.
  • 4. Bleeding in joint 2 week prior to assessment.

About Cairo University

Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.

Locations

Cairo, , Egypt

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported